email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2637-4706

Drug Designing & Intellectual Properties International Journal

Research Article(ISSN: 2637-4706)

Preparation and Evaluation of Micro particulate Drug Delivery Systems of Gliclazide Employing Starch Acetate

Volume 1 - Issue 1

P Veera LakshmiM1, KPR Chowdary2*, A Prameela Rani3 and VUM Prasad4

  • Author Information Open or Close
    • 1PhD Scholar, School of Pharmacy, JNTUK India
    • 2Research Director, Vikas Institute of Pharmaceutical Sciences India
    • 3University College of Pharmaceutical Sciences, ANU India
    • 4Programme Director, School of Pharmacy, JNTUK India

    *Corresponding author: KPR Chowdary, Research Director, Vikas Institute of Pharmaceutical Sciences India

Received: March 11, 2018;   Published: March 19, 2018

DOI: 10.32474/DDIPIJ.2018.01.000103

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Recently much emphasis is being laid on the development of micro particulate DDS in preference to single unit systems because of their potential benefits such as increased bioavailability, reduced risk of systemic toxicity, reduced risk of local irritation and predictable gastric emptying. The objective of the present study is to prepare and evaluate micro particulate drug delivery systems of Gliclazide using starch acetate, a new modified starch for oral controlled release. The starch acetate (DS 2.75) was freely soluble in chloroform and insoluble in several aqueous fluids and organic solvents. Chloroform could be used as solvent for starch acetate in the preparation of micro particles, microcapsules and in film coating Spherical starch acetate- Gliclazide micro particles could be prepared by the emulsification-solvent evaporation method. The method is industrially feasible as it involves emulsification and removal of the solvent, which can be controlled precisely. The emulsification solvent evaporation method was reproducible with regard to size and size distribution of the micro particles. About 65-70% of micro particles in each batch were in the size range 35/50 mesh (398.5μm) Encapsulation efficiency was in the range 96.0-99.3 % in the preparation of micro particles.

Gliclazide release from the starch acetate micro particles was slow and spread over longer periods of time. The drug release depended on the proportion of core: coat in the micro particles. A good linear relationship (R²=0.826) between percent coat and release rate (ko) was observed. The relationship could be expressed by the linear equation, y=12.18-0.173x where x is percent coat and y is release rate (ko). Gliclazide release from the starch acetate micro particles was by non fickian (anomalous) diffusion. Formulation F2 prepared using a Core: coat ratio of 8:2 gave slow, controlled and complete release (100%) of Gliclazide over 12 hours. As such formulation F2 is considered as a promising micro particulate DDS for oral control release of Gliclazide over 12 hours for b.i.d administration

Keywords: Multi particulate drug delivery systems; Starch acetate; Gliclazide; Oral controlled release

Abstract| Introduction| Materials and Methods| Results and Discussion| Conclusion| References|

https://www.high-endrolex.com/21